CLC bio Japan Provides High-Throughput Sequence Analysis Infrastructure to RIKEN Omics Science Center

YOKOHAMA, Japan & AARHUS, Denmark--(BUSINESS WIRE)--Today, RIKEN and CLC bio Japan announced an agreement for the purchase of CLC bio’s enterprise platform software by RIKEN Omics Science Center (OSC). CLC bio’s high-throughput sequence analysis infrastructure will empower both OSC's scientists and OSC’s Genome Network Analysis Service (GeNAS) with a user-friendly and fast workflow to efficiently manage and analyze large quantities of genomics data.
MORE ON THIS TOPIC